Altimmune, Inc. (ALT) Financial Statements (2026 and earlier)

Company Profile

Business Address 910 CLOPPER ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments273,456131,891197,815184,880190,301215,923
Cash and cash equivalent43,76036,926135,117111,097190,301115,918
Short-term investments229,69694,96562,69873,783 100,006
Restricted cash and investments424241343434
Receivables  1001734,02912,373
Other undisclosed current assets4,6945,32111,6707,7269,7621,927
Total current assets:278,192137,254209,626192,813204,126230,257
Noncurrent Assets
Operating lease, right-of-use asset      904
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization3124136511,0811,4481,057
Intangible asset, including goodwill, after accumulated amortization    12,41912,41912,824
Intangible asset, excluding goodwill, after accumulated amortization    12,41912,41912,824
Other noncurrent assets1,4251,63936361587273
Total noncurrent assets:1,7372,0521,01414,11514,73914,858
TOTAL ASSETS:279,929139,306210,640206,928218,865245,115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,6313,7465,8028,0354,74412,020
Employee-related liabilities✕✕✕✕✕2,313 
Accounts payable2,7172112,0704,8042,034612
Accrued liabilities5,9143,5353,7323,23139611,408
Business combination, contingent consideration, liability     6,090 
Other undisclosed current liabilities6,3666,7226,3419,0197,442 
Total current liabilities:14,99710,46812,14317,05418,27612,020
Noncurrent Liabilities
Long-term debt and lease obligation34,287  4,5811,4541,828
Long-term debt, excluding current maturities34,287  4,5811,4541,828
Liabilities, other than long-term debt5,7531,424215  5,390
Other liabilities5,7532240   
Operating lease, liability  1,402175   
Business combination, contingent consideration, liability      5,390
Other undisclosed noncurrent liabilities  3,9064,183   
Total noncurrent liabilities:40,0405,3304,3984,5811,4547,218
Total liabilities:55,03715,79816,54121,63519,73019,239
Equity
Equity, attributable to parent224,892123,508194,099185,293199,135225,876
Common stock1177544
Additional paid in capital879,292689,864665,427568,399497,342417,338
Accumulated other comprehensive loss(4,928)(4,973)(5,004)(5,227)(5,040)(5,045)
Accumulated deficit(649,483)(561,390)(466,331)(377,884)(293,171)(186,421)
Total equity:224,892123,508194,099185,293199,135225,876
TOTAL LIABILITIES AND EQUITY:279,929139,306210,640206,928218,865245,115

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues4120426(68)4,4108,185
Gross profit:4120426(68)4,4108,185
Operating expenses(94,530)(103,192)(96,355)(87,672)(101,324)(62,984)
Operating loss:(94,489)(103,172)(95,929)(87,740)(96,914)(54,799)
Nonoperating income (expense)5,7158,1137,4822,830(177)337
Investment income, nonoperating7,5418,0747,3512,870203323
Other nonoperating income (expense)(190)48166(32)(374)24
Interest and debt expense(1,636)(9)(35)(8)(6)(9)
Loss from continuing operations before equity method investments, income taxes:(90,410)(95,068)(88,482)(84,918)(97,096)(54,471)
Other undisclosed income from continuing operations before income taxes1,636935869
Loss from continuing operations before income taxes:(88,774)(95,059)(88,447)(84,910)(97,091)(54,462)
Income tax benefit 681  197 5,417
Loss from continuing operations:(88,093)(95,059)(88,447)(84,713)(97,091)(49,044)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(97,091)(49,044)
Net loss available to common stockholders, diluted:(88,093)(95,059)(88,447)(84,713)(97,091)(49,044)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(88,093)(95,059)(88,447)(84,713)(97,091)(49,044)
Other undisclosed comprehensive income (loss)4531223(187)4(24)
Comprehensive loss, net of tax, attributable to parent:(88,048)(95,028)(88,224)(84,900)(97,086)(49,069)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: